agilon health, inc. Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims
agilon health, inc. (AGL) reported Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims of $2.57 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 · last filed 2026-08-05
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-06-30 was $1.30B, a 10.31% decline year-over-year.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-03-31 was $1.27B, a 9.43% decline year-over-year.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-12-31 was $1.64B, a 8.08% increase year-over-year.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-09-30 was $1.49B, a 1.09% decline year-over-year.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2025 was $5.98B, a 2.32% increase from fiscal 2024.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2024 was $5.84B, a 36.54% increase from fiscal 2023.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2023 was $4.28B, a 78.30% increase from fiscal 2022.
- agilon health, inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2022 was $2.40B, a 45.73% increase from fiscal 2021.
| Period end | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 3 month | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 6 month | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 9 month | Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.30B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.57B 10-Q · filed 2026-08-05 | $4.21B derived: sum of 3 quarters · filed 2026-08-05 | $5.70B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.27B 10-Q · filed 2026-05-06 | $2.91B derived: sum of 2 quarters · filed 2026-05-06 | $4.40B derived: sum of 3 quarters · filed 2026-05-06 | $5.85B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.64B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.13B derived: sum of 2 quarters · filed 2026-02-25 | $4.58B derived: sum of 3 quarters · filed 2026-08-05 | $5.98B 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.49B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.93B derived: sum of 2 quarters · filed 2026-08-05 | $4.34B 10-Q · filed 2025-11-04 | $5.86B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.45B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.85B 10-Q · filed 2026-08-05 | $4.37B derived: sum of 3 quarters · filed 2026-08-05 | $5.87B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.40B 10-Q · filed 2026-05-06 | $2.92B derived: sum of 2 quarters · filed 2026-05-06 | $4.43B derived: sum of 3 quarters · filed 2026-05-06 | $5.80B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.52B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.02B derived: sum of 2 quarters · filed 2026-02-25 | $4.40B derived: sum of 3 quarters · filed 2026-02-25 | $5.84B 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.51B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.88B derived: sum of 2 quarters · filed 2025-11-04 | $4.32B 10-Q · filed 2025-11-04 | $5.52B derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.37B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $2.82B 10-Q · filed 2025-08-04 | $4.01B derived: sum of 3 quarters · filed 2026-02-25 | $5.12B derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.44B 10-Q · filed 2025-05-06 | $2.64B derived: sum of 2 quarters · filed 2026-02-25 | $3.74B derived: sum of 3 quarters · filed 2026-02-25 | $4.75B derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.19B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.30B derived: sum of 2 quarters · filed 2026-02-25 | $3.31B derived: sum of 3 quarters · filed 2026-02-25 | $4.28B 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.10B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.11B derived: sum of 2 quarters · filed 2024-11-07 | $3.09B 10-Q · filed 2024-11-07 | $3.71B derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.01B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.98B 10-Q · filed 2024-08-06 | $2.61B derived: sum of 3 quarters · filed 2025-02-25 | $3.23B derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $972.83M 10-Q · filed 2024-05-07 | $1.60B derived: sum of 2 quarters · filed 2025-02-25 | $2.22B derived: sum of 3 quarters · filed 2025-02-25 | |
| 2022-12-31 | $628.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.25B derived: sum of 2 quarters · filed 2025-02-25 | $2.40B 10-K · filed 2025-02-25 | |
| 2022-09-30 | $618.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.77B 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $1.15B 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $1.65B 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |